Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zunino

Showing results (101-110 of 204) with videos related to

Pageof 21
Sort By:
Cancer Research|March 10, 1999
A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenograftsD Polizzi, G Pratesi, M Tortoreto, et al.
Tumori|August 31, 1983
Effectiveness of laser photoradiation therapy following hematoporphyrin derivative administration in the experimental MS-2 tumor modelF Zunino, R Marchesini, E Melloni, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Spontaneous lung metastases in a human lung tumor xenograft: a new experimental modelC Corti, G Pratesi, M DeCesare, et al.
Molecular Pharmacology|May 1, 1993
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effectsP De Isabella, G Capranico, M Palumbo, et al.
Anti-Cancer Drugs|July 1, 1996
Modulation of melphalan cytotoxic activity in human melanoma cell linesR Supino, C Caserini, L Orlandi, et al.
Molecular Pharmacology|May 1, 1994
Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistanceG Capranico, R Supino, M Binaschi, et al.
Cancer Research|May 15, 1998
Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analoguesM Binaschi, R Farinosi, C A Austin, et al.
British Journal of Cancer|December 1, 1985
Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drugG Pratesi, G Savi, G Pezzoni, et al.
Cancer Letters|November 15, 1989
Changes in the three-dimensional organization of LoVo cells associated with resistance to doxorubicinC Soranzo, A Ingrosso, M Buffa, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriersF Zunino, G Savi, F Giuliani, et al.
Pageof 21

Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Cancer Research|March 10, 1999
A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenograftsD Polizzi, G Pratesi, M Tortoreto, et al.
Tumori|August 31, 1983
Effectiveness of laser photoradiation therapy following hematoporphyrin derivative administration in the experimental MS-2 tumor modelF Zunino, R Marchesini, E Melloni, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Spontaneous lung metastases in a human lung tumor xenograft: a new experimental modelC Corti, G Pratesi, M DeCesare, et al.
Molecular Pharmacology|May 1, 1993
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effectsP De Isabella, G Capranico, M Palumbo, et al.
Anti-Cancer Drugs|July 1, 1996
Modulation of melphalan cytotoxic activity in human melanoma cell linesR Supino, C Caserini, L Orlandi, et al.
Molecular Pharmacology|May 1, 1994
Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistanceG Capranico, R Supino, M Binaschi, et al.
Cancer Research|May 15, 1998
Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analoguesM Binaschi, R Farinosi, C A Austin, et al.
British Journal of Cancer|December 1, 1985
Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drugG Pratesi, G Savi, G Pezzoni, et al.
Cancer Letters|November 15, 1989
Changes in the three-dimensional organization of LoVo cells associated with resistance to doxorubicinC Soranzo, A Ingrosso, M Buffa, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriersF Zunino, G Savi, F Giuliani, et al.
Pageof 21